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Abstract: Introduction: Some studies have reported creatinine phosphokinase (CPK) as a new emerging way in predicting
the outcomes of poisoned patients. This study aimed to evaluate the association of serum CPK level in the first
24 hours with outcomes of poisoned patients. Methods: This retrospective cross-sectional study was performed
using the medical profiles of poisoned patients aged between 13 and 70 years old who were referred to the
emergency department of a big referral medical toxicology center during 6 years and whose necessary data
for this study was available. Results: 318 patients with the mean age of 34.9±14.5 years were studied (77.1%
male). The mean serum CPK level of patients was 4693.1 ± 10303.8 (35–89480) IU/L. There was no significant
correlation between serum CPK level and cause of poisoning (r= 0.16; p=0.51), age (r = -0.021; p = 0.651), sex (r =
0.131; p = 0.281), seizure (r = -0.022; p = 0.193), level of consciences (r = -0.138; p = 0.167), and duration of hospital
stay (r= 0.242, p = 0.437). The mean serum CPK level was significantly higher in ICU admitted (p<0.0001), AKI
(p<0.0001), hyperkalemia (p<0.0001), hypophosphatemia (p=0.045), and hypocalcaemia (p=0.008) cases. The
best cut off point of serum CPK level in predicting acute kidney injury (AKI) was estimated to be 10000 IU/L
(sensitivity = 83.8% and specificity = 68.8%). Conclusion: It seems that CPK could be considered as a candidate
tool for screening the intoxicated patients in need for ICU admission and at risk for AKI.
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1. Introduction
Acute poisoning is a major and common cause of mortal-
ity worldwide, especially in developing and low income
countries (1). Based on World Health Organization (WHO)
reports, poisoning is responsible for 45000 deaths per
year in people younger than twenty years old (available on:
http://www.who.int/violence_injury_prevention/child/injur
y/world_report/Poisoning_english.pdf). Developing out-
come prediction tools for screening and disposition of these
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patients is one of the interesting fields of research. Some
studies have reported that serum creatine phosphokinase
(CPK) level may become a newly emerging way in prediction
of poisoning severity and outcome (1-4). It has been shown
that CPK more than 10000 IU/L in poisoned patients could
be associated with more complications (3, 5). CPK increase
occurs in acute muscle necrosis and rhabdomyolysis. There
are some possible mechanisms for increase of serum CPK
in poisoning patients (6, 7). Toxic serum level of any drug,
muscle necrosis following substance overdose, seizure and
serotonergic and neuroleptic syndromes may be possible
causes of increase in the CPK level in poisoned patients (8, 9).
This study aimed to evaluate the association of serum CPK
level in the first 24 hours with outcomes of poisoned patients.
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2. Methods
2.1. Study design and setting
This retrospective cross-sectional study was performed on
medical profiles of poisoning patients who were referred to
emergency department (ED) of Loghman Hakim Educational
Hospital, Tehran, Iran, between July 2011 and July 2017.
Loghman Hakim Hospital is a big referral toxicology center
in the Middle East. This study was approved by Research
Ethics Committee of Shahid Beheshti University of Medical
Sciences and Health Services.
2.2. Participants
Using census sampling, patients who were at least 13 years
old and were referred to the mentioned ED and whose nec-
essary data for this study was available (e.g.: serum CPK level
of the first 24 hours of admission) were evaluated. Patients
with recent trauma, myocardial infarction (MI), cerebrovas-
cular accident (CVA), cardiopulmonary resuscitation (CPR)
or surgery in the past 6 months, pregnancy or lactation, renal
or hepatic diseases, and history of substance or fitness drug
use were excluded. Creatinine ≥ 1.8 mg/dl was considered as
acute kidney injury (AKI).
2.3. Data gathering
Data gathering was performed using a checklist that con-
sisted of demographic variables, consciousness level based
on Glasgow coma scale (GCS), history of hematuria and
seizure, urinary output, serum CPK level, blood urea nitrogen
(BUN), creatinine level in the first 24 hours of admission, and
outcomes (disposition, need for dialysis, acute kidney injury
(AKI), mortality, need for intubation and need for ICU admis-
sion). A trained toxicology resident was responsible for gath-
ering data from the patients’ profiles.
2.4. Statistical analysis
Data were analyzed using IBM SPSS statistical software
(Chicago, USA) version 22 and t- test and chi square tests. P<
0.05 was considered significant. Findings were presented us-
ing mean ± standard deviation or frequency and percentage.
Chi square, Fisher’s exact, and student t tests were used for
comparisons. Area under the receiver operating characteris-
tic (ROC) curve was used for estimating the best cutoff point
of serum CPK in predicting the occurrence of AKI.
3. Results:
3.1. Baseline characteristics
318 patients with the mean age of 34.9±14.5 (13-85) years
were studied (77.1% male). Baseline characteristics of partic-
Table 1: Baseline characteristics of studied patients
Variable Values
Sex
Female 72 (22.9)
Male 243 (77.1)
Age group (year)
< 18 19 (6.0)
18 - 35 163 (51.4)
35- 60 102 (32.2)
≥60 33 (10.4)
Seizure
Yes 51 (18.7)
No 222 (81.3)
Hematuria
Yes 2 (0.8)
No 260 (99.2)
GCS
Mild (14- 15) 56 (21.0)
Moderate (9- 13) 102 (38.4 )
Severe (3- 8) 105 (39.6 )
Vital signs
Systolic blood pressure (mmHg) 107.67 ± 21.50
Pulse rate (/minute) 97 ± 26
Respiration rate (/minute) 19 ± 4
Oxygen Saturation (%) 88.6 ± 12.3
Urinary Output (ml)
1s t day 1856.9 ± 1533.9
2n d day 2832.2 ± 2462.1
3r d day 2941.4 ± 1768.7
4t h day 3316.4 ± 2009.6
Creatine phosphokinase (IU/L)
<1000 150 (50.5)
1000- 5000 74 (24.9)
5000- 10000 36 (12.1)
10000-15000 12(4.0)
15000-20000 6 (2.4)
>20000 19 (6.4)
Data are presented as mean ± standard devia-
tion or number (%). There is missing data in
some variables.
Table 2: Causes of poisoning in the studied patients
Cause Number (%)
Neuropsychiatric drugs 135 (42.4)
Acetaminophen 70 (22.1)
Alcohol 63 (19.8)
Opium 29 (9.1)
Carbone monoxide 7 (2.2)
Other 14 (4.4)
ipants are shown in table 1. The most important cause of poi-
soning were benzodiazepines (24.6%) and acetaminophen
(22.1%), respectively (table 2). Mean serum blood urea nitro-
gen (BUN) and creatinine levels of the studied patients were
52.89 ± 46.1 mg/dl and 1.7 ± 1.2 mg/dl, respectively. Patients
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jemerg.com
3 Emergency. 2018; 6 (1): e56
Figure 1: Area under the receiver operating characteristic (ROC)
curve of serum creatine phosphokinase (CPK) level of poisoned pa-
tients on the first day in predicting acute Kidney injury (p< 0.0001).
were hospitalized for 12.74 ± 12.05 (1-72) days on average.
The mean serum CPK level of studied patients was 4693.1
± 10303.8 (35–89480) IU/L. There was no significant corre-
lation between serum CPK level and cause of poisoning (r=
0.16; p=0.51), age (r = -0.021; p = 0.651), sex (r = 0.131; p =
0.281), seizure (r = -0.022; p = 0.193), level of consciences (r =
-0.138; p = 0.167), and duration of hospital stay (r= 0.242, p =
0.437).
3.2. Outcomes
37 (11.6%) cases were admitted to intensive care unit (ICU),
83 (26.1%) died, and 198 (62.3%) were discharged from hos-
pital. AKI was developed in 79 (26.5%) cases out of which 14
(17.7%) needed dialysis. Table 3 compares the mean serum
CPK level of patients based on the studied outcomes. The
mean serum CPK level was significantly higher in ICU ad-
mitted (p<0.0001), AKI (p<0.0001), hyperkalemia (p<0.0001),
hypophosphatemia (p=0.045), and hypocalcaemia (p=0.008)
cases. Figure 1 shows the area under the ROC curve of first
day serum CPK level in predicting AKI (AUC= 0.752, 95%CI:
0.688-0.815; p< 0.0001). The best cut off point of serum CPK
level in this regard was estimated to be 10000 IU/L based on
the ROC curve analysis (sensitivity = 83.8% and specificity =
68.8%).
4. Discussion
Based on the results of the present study, there was a signif-
icant correlation between serum CPK level of poisoned pa-
tients and need for ICU admission and AKI development.
The best CPK cut off point in predicting AKI was 10000 IU/L.
There was no significant correlation between serum CPK
level and age, sex, level of conciseness, seizure, need for intu-
bation, duration of hospital stay, and mortality. Some of the
patients that survive poisoning face mortality due to other
side effects. Rhabdomyolysis and its side effects including
AKI should be counted as common complications in these
patients. If the definition of rhabdomyolysis is considered
CPK level over 1000 IU/L, the prevalence of rhabdomyolysis
in the patients studied in the present research will be about
50% and this emphasizes the necessity of paying attention to
this matter. Mild and moderate rhabdomyolysis by itself is
a curable and self-limiting problem but there is controversy
regarding the level of CPK that is associated with nephrotox-
icity and kidney failure. This level was estimated at 15000
IU/L and higher in patients with traumatic rhabdomyolysis
following Bam earthquake (10-12). It seems that the cause of
rhabdomyolysis affects the toxic level of this enzyme. What
can be concluded from the findings of the present study is
that poisoned patients with serum level of 10000 IU/L and
higher are at a significant risk of nephrotoxicity and AKI due
to it. Eizadi et al. (2012) study showed that higher levels
of serum CPK level correlated with a higher risk of develop-
ing complications, increased need for dialysis and mortality
(13). Our findings were similar regarding the increasing risk
of complication development such as AKI but we had differ-
ent findings regarding the correlation of serum CPK levels
and need for dialysis and mortality. Dadpour et al. (2017)
showed that, about 80% of patients with serum CPK level >
10000 IU/L, were in need of dialysis (14). In the present study,
there was no significant correlation between CPK level and
need for dialysis. Only 22.2% of cases in need of dialysis had
CPK > 10000 IU/L in this study. Nevertheless, it should be
noted that rhabdomyolysis is not the sole cause of AKI in poi-
soning patients and unlike traumatic rhabdomyolysis cases
in which CPK nephrotoxicity could be considered the cause
of AKI with higher confidence, here more caution should be
taken while interpreting the findings. It seems that when fac-
ing this type of patients, screening cases with a higher level of
muscular enzymes, as well as considering other conditions, is
a wise thing to do for referring them to more advanced cen-
ters with better treatment equipment.
5. Limitations
The limitation of this study was performing it in a retrospec-
tive manner and having missing data.
6. Conclusion
Based on the results of the present study, there was a signif-
icant correlation between serum CPK level of poisoned pa-
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Table 3: Outcomes of studied patients and its relation with serum creatine phosphokinase (CPK) levels in the first 24 hours
Outcome Number (%) CPK level P value
Treated and discharged
Yes 196 (61.6) 4296.8±9240.5 0.323
No 122 (38.4) 5636.4±10288.3
Intubation
Yes 98 (30.8) 5385.8±9719.9 0.216
No 193 (66.2) 3975.7±8369.8
ICU admission
Yes 37 (11.6) 21519.9±17582.8 <0.0001
No 281 (88.4) 2246.9±3798.9
Acute kidney injury
Yes 76 (25.9) 11731.6±15406.2 <0.0001
No 217 (74.1) 2222.9±4274.5
Dialysis
Yes 29 (9.1) 7968.1±12763.4 0.062
No 289 (90.9) 4338.2±9202.8
Mortality
Yes 83 (26.1) 4524.9±9168.0 0.873
No 235 (73.9) 4732.5±9798.8
Hyperkalemia
Yes 76 (23.9) 8930.3±14716.6 <0.0001
No 242 (76.1) 1796.7±5782.9
Hyperphosphatemia
Yes 31 (27.4) 8663.2±13855.8 0.045
No 82 (72.6) 4036.7±9243.1
Hypocalcemia
Yes 69 (56.6) 8170.3±12647.8 0.008
No 53 (43.4) 2797.1±7855.1
tients and need for ICU admission and AKI development.
The best CPK cut off point in predicting the AKI was 10000
IU/L. There was no significant correlation between serum
CPK level and age, sex, level of conciseness, seizure, need for
intubation, duration of hospital stay, and mortality.
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